The Government of India, through the National Pharmaceutical Pricing Authority (NPPA), has capped the trade margin at 30% on 137 anti-cancer medicines. The aim is to make cancer treatment more affordable for patients.
Patients and partners with questions about the revised prices are welcome to speak to their doctor, pharmacist or hospital.
Source: NPPA Order S.O. 5690(E), The Gazette of India, 17 October 2026.
AURA Division specialises in Antiretroviral therapies and viral disease management. With a strong legacy of expertise in HIV care, tuberculosis, latent TB infection and other anti-infectives, this division provides a vast range of treatment solutions that aim at improving patient adherence and therapeutic outcomes.
Through Hetero Healthcare’s commitment to innovation, affordability and excellence, the AURA division continues to support doctors with trusted therapies that address evolving patient needs in infectious disease management.
View by-
